
Dognosis develops breath-based diagnostic tools for early disease detection, starting with cancer.
Dognosis is an Indian deep-tech health technology startup developing AI-powered, non-invasive disease detection solutions by combining the extraordinary olfactory abilities of trained dogs with brain-computer interface (BCI) technology and machine learning. Its proprietary platform, comprising DogSense (a canine BCI) and DogOS (an AI-powered analytics platform), translates canine scent detection into digital signals for accurate disease screening. The company's flagship solution, BreathEasy, is a breath-based multi-cancer early detection (MCED) test that analyzes volatile organic compounds (VOCs) associated with disease. By integrating canine intelligence with advanced AI, Dognosis aims to provide an affordable, scalable, and highly accurate screening tool for early disease detection, helping improve patient outcomes through earlier diagnosis.
Frequently Asked Questions